Valproic acid alleviates generalized hyperalgesia in mice with induced adenomyosis

Journal of Obstetrics and Gynaecology Research - Tập 37 Số 7 - Trang 696-708 - 2011
Xishi Liu1, Sun‐Wei Guo1
1Shanghai Obstetrics and Gynecology Hospital, Shanghai College of Medicine, Fudan University, Shanghai, China

Tóm tắt

Abstract

Emerging evidence suggests that adenomyosis, like endometriosis, may also be an epigenetic disease. In this study, we evaluated the effect of valproic acid (VPA) in ICR mice with adenomyosis, induced by neonatal dosing with tamoxifen. For all mice, we evaluated the bodyweight and the response to thermal stimuli by hotplate and tail‐flick tests 4, 8, and 12 weeks after dosing, respectively, and then treated mice with low‐ and high‐dose of VPA, progesterone (P4), P4 + VPA, or vehicle only. Three weeks after treatment, both bodyweight and thermal response tests were evaluated again before sacrifice, and the depth of myometrial infiltration was evaluated. We found that: (i) the induction of adenomyosis resulted in progressive generalized hyperalgesia as measured by hotplate and tail‐flick tests, along with decreased bodyweight; (ii) treatment with VPA, P4, or a combination was efficacious in improving generalized hyperalgesia; and (iii) drug treatment appeared to reduce the myometrial infiltration, but the difference did not reach statistical significance. Thus, VPA seems to be a promising therapeutics for treating adenomyosis, as reported recently in some case series in humans.

Từ khóa


Tài liệu tham khảo

10.1016/j.bpobgyn.2006.01.016

10.1016/j.bpobgyn.2006.01.012

10.1016/S0889-8545(02)00053-0

10.1093/molehr/gap064

10.1016/j.fertnstert.2006.11.009

10.4161/epi.1.2.2766

10.1177/1933719110377118

10.1177/1933719110373807

10.1093/humrep/dep472

10.1016/S0002-9440(10)61733-6

10.1016/j.etp.2004.10.001

10.1177/1933719111404610

Council NR, 1996, Guide for the Care and Use of Laboratory Animals

10.1016/0002-9378(72)90781-8

Le Bars D, 2001, Animal models of nociception, Pharmacol Rev, 53, 597

10.1002/0471142301.ns0809s41

Kooperberg C, 1997, Polychotomous regression, J Am Statist Assoc, 92, 117, 10.1080/01621459.1997.10473608

Team RDC, 2010, R: A Language and Environment for Statistical Computing

10.1159/000093975

10.1038/embor.2009.88

10.1074/jbc.M703586200

Dong XF, 2007, Histone deacetylase inhibitor valproic acid inhibits proliferation and induces apoptosis in KM3 cells via downregulating VEGF receptor, Neuro Endocrinol Lett, 28, 775

10.1093/humrep/deq311

Kogan EA, 2010, [The morphological and immunohiochemical features of foci of adenomyosis: in its concurrence with endometrial adenocarcinoma], Arkh Patol, 72, 7

10.1124/mol.107.042838

10.1016/j.jpain.2009.06.012

10.1016/j.ejogrb.2007.01.015

10.1016/j.fertnstert.2006.01.030

10.1177/1933719110381927

10.1007/s11064-008-9700-2

10.2174/1876386300902010011

10.1016/j.pain.2008.01.020

10.1186/1744-8069-6-51

10.2165/00002018-200124130-00004

10.1073/pnas.171616898

10.1016/j.jpain.2006.01.447

10.1016/j.bpobgyn.2006.01.003

10.1038/bjc.1967.15

10.1159/000145724

10.1016/0024-3205(81)90234-4

Mori T, 1998, Animal model of uterine adenomyosis: induction of the lesion in rats by ectopic pituitary isografting, Lab Anim Sci, 48, 64

10.1016/S0015-0282(97)00193-3

10.1056/NEJMcp1000274

10.1016/j.ajog.2009.11.035

10.1007/s00261-006-9152-6

10.1016/j.ejogrb.2006.07.034

10.1177/1933719107302913

10.1159/000279324

IgarashiM YokotaY IgarashiT IgarashiS AbeY LiangS.Novel transvaginal echo‐guided injection treatment for adenomyosis vaginal and deep endometriosis and ovarian endometriosis with a danazol 3‐ethyl pyridine or valproic acid solution. The First Asian Conference on Endometriosis Shanghai 2010.